| Fc gamma receptor polymorphisms as predictive markers of Cetuximab efficacy in epidermal growth factor receptor downstream-mutated metastatic colorectal cancer J Rodríguez, R Zarate, E Bandres, V Boni, A Hernández, JJ Sola, ... European journal of cancer 48 (12), 1774-1780, 2012 | 101 | 2012 |
| Dysregulation of apoptosis is a major mechanism in the lymph node involvement in colorectal carcinoma E Bandres, V Catalan, I Sola, B Honorato, E Cubedo, L Cordeu, E Andion, ... Oncology reports 12 (2), 287-292, 2004 | 88 | 2004 |
| A gene signature of 8 genes could identify the risk of recurrence and progression in Dukes' B colon cancer patients E Bandrés, R Malumbres, E Cubedo, B Honorato, R Zarate, A Labarga, ... Oncology reports 17 (5), 1089-1094, 2007 | 73 | 2007 |
| Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patients E Bandrés, R Barricarte, C Cantero, B Honorato, R Malumbres, R Zárate, ... Oral oncology 43 (7), 713-719, 2007 | 54 | 2007 |
| Androgen receptor mutations are associated with Gleason score in localized prostate cancer D Sanchez, D Rosell, B Honorato, J Lopez, J Arocena, G Sanz BJU international 98 (6), 1320-1325, 2006 | 31 | 2006 |
| Gene expression profile induced by BCNU in human glioma cell lines with differential MGMT expression E Bandres, E Andion, A Escalada, B Honorato, V Catalan, E Cubedo, ... Journal of neuro-oncology 73, 189-198, 2005 | 24 | 2005 |
| Gene expression profile of ewing sarcoma cell lines differing in their EWS-FLI1 fusion type E Bandrés, R Malumbres, A Escalada, E Cubedo, I González, B Honorato, ... Journal of Pediatric Hematology/Oncology 27 (10), 537-542, 2005 | 15 | 2005 |
| Carcinogénesis colónica: proceso de transformación neoplásica J Garcia-Foncillas, E Salgado, R Zarate, M Zabalegui, E Bandres, ... Servicio de Publicaciones de la Universidad de Navarra, 2003 | 12 | 2003 |
| mitochondrial defects in breast cancer J Salgado, B Honorato, J García-Foncillas Clinical medicine. Oncology 2, CMO. S524, 2008 | 11 | 2008 |
| TAK1 mRNA expression in the tumor tissue of locally advanced head and neck cancer patients B Honorato, J Alcalde, R Martinez-Monge, N Zabalegui, ... Gene Regulation and Systems Biology 2, 117762500800200002, 2008 | 6 | 2008 |
| " DETERMINA KRAS''PROJECT: WHAT'S NEW AFTER TWENTY MONTHS? J García-Foncillas, B Honorato, L Hernando, I Bando, J Hernandez-Losa, ... ANNALS OF ONCOLOGY 21, 192-192, 2010 | 2 | 2010 |
| Susceptibilidad genética en cáncer de colon N Zabalegui, R Zarate, V Catalan, B Honorato, F García, E Bandres, ... Revista de Medicina de la Universidad de Navarra, 20-23, 2003 | 2 | 2003 |
| Mutations of the androgen receptor gene in patients with clinically localized adenocarcinoma of the prostate DS Zalabardo, DR Costa, BH Cia, JR Zuazu, JMR Balboa, JMF Montero, ... Actas urologicas espanolas 28 (3), 221-229, 2004 | 1 | 2004 |
| Role of polymorphic fc gamma receptor II/III in the efficacy of cetuximab in KRAS-NRAS-BRAF-PI3K mutated. J Garcia-Foncillas, J Rodriguez, V Boni, I Sola, B Honorato, R Zarate, ... Journal of Clinical Oncology 30 (4_suppl), 477-477, 2012 | | 2012 |
| Fc gamma receptor polymorphisms and KRAS status as predictive biomarkers in patients with metastatic colorectal cancer treated with biweekly cetuximab-based salvage therapy. R Zarate, E Bandres, J Rodriguez, N Bitarte, B Honorato, V Boni, I Sola, ... Journal of Clinical Oncology 28 (15_suppl), e13523-e13523, 2010 | | 2010 |
| 6101 “Determina KRAS” Project: what have we learned after nine months? J Garcia-Foncillas, B Honorato, T Caldes, J Hernandez, S Landolfi, ... Ejc Supplements 2 (7), 353, 2009 | | 2009 |
| Valor clínico de la detección de enfermedad mínima residual en cáncer de colon B Honorato, F García, E Bandrés, R Zárate, V Catalán, E Cubedo, ... Revista de Medicina de la Universidad de Navarra, 31-34, 2003 | | 2003 |
| Alteraciones citogenéticas en el cáncer colorrectal R Zárate, V Catalán, B Honorato, F García, E Bandrés, N Zabalegui, ... Revista de Medicina de la Universidad de Navarra, 24-30, 2003 | | 2003 |
| Farmacogenómica en el cáncer colorrectal E Bandres, N Zabalegui, R Zarate, V Catalan, B Honorato, F García, ... Revista de Medicina de la Universidad de Navarra, 39-45, 2003 | | 2003 |
| El receptor del factor de crecimiento epitelial EGFR como diana terapéutica en cáncer colorrectal F García, E Bandrés, N Zabalegui, R Zarate, V Catalán, B Honorato, ... Revista de Medicina de la Universidad de Navarra, 46-48, 2003 | | 2003 |
